| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 18 | 2022 | 756 | 3.310 |
Why?
|
| Scleroderma, Systemic | 7 | 2023 | 446 | 2.250 |
Why?
|
| DNA Methylation | 4 | 2023 | 193 | 2.240 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2021 | 786 | 1.530 |
Why?
|
| Genome-Wide Association Study | 9 | 2022 | 240 | 0.880 |
Why?
|
| Twins, Monozygotic | 2 | 2021 | 27 | 0.870 |
Why?
|
| Diseases in Twins | 2 | 2021 | 31 | 0.860 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2022 | 627 | 0.860 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 163 | 0.820 |
Why?
|
| Autoimmunity | 1 | 2021 | 118 | 0.710 |
Why?
|
| Fibroblasts | 2 | 2021 | 902 | 0.670 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1293 | 0.640 |
Why?
|
| Genetics, Population | 2 | 2017 | 21 | 0.630 |
Why?
|
| Selection, Genetic | 2 | 2017 | 49 | 0.620 |
Why?
|
| Rheumatic Diseases | 1 | 2017 | 35 | 0.590 |
Why?
|
| Interferons | 2 | 2021 | 36 | 0.590 |
Why?
|
| Autoimmune Diseases | 3 | 2015 | 186 | 0.540 |
Why?
|
| Genetic Loci | 2 | 2013 | 59 | 0.490 |
Why?
|
| Gene Regulatory Networks | 3 | 2019 | 94 | 0.470 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 91 | 0.460 |
Why?
|
| Genotype | 9 | 2021 | 785 | 0.450 |
Why?
|
| Chromosome Mapping | 5 | 2017 | 188 | 0.450 |
Why?
|
| Case-Control Studies | 7 | 2022 | 1549 | 0.430 |
Why?
|
| Lupus Nephritis | 2 | 2014 | 193 | 0.420 |
Why?
|
| Humans | 36 | 2023 | 68549 | 0.420 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 103 | 0.420 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2011 | 2 | 0.410 |
Why?
|
| Receptors, Interleukin | 1 | 2011 | 22 | 0.410 |
Why?
|
| Immunity, Innate | 1 | 2012 | 156 | 0.400 |
Why?
|
| Alleles | 8 | 2019 | 386 | 0.380 |
Why?
|
| Boron Neutron Capture Therapy | 2 | 2021 | 3 | 0.370 |
Why?
|
| Autoantibodies | 2 | 2019 | 434 | 0.370 |
Why?
|
| Genetic Variation | 5 | 2018 | 220 | 0.360 |
Why?
|
| Gene Ontology | 2 | 2021 | 31 | 0.360 |
Why?
|
| CpG Islands | 2 | 2021 | 51 | 0.360 |
Why?
|
| HLA Antigens | 4 | 2019 | 82 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 614 | 0.350 |
Why?
|
| Chickens | 3 | 1999 | 232 | 0.340 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 41 | 0.340 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 120 | 0.320 |
Why?
|
| Software | 2 | 2022 | 418 | 0.310 |
Why?
|
| Pedigree | 2 | 2012 | 159 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 529 | 0.290 |
Why?
|
| Myocardium | 1 | 2012 | 1204 | 0.280 |
Why?
|
| Genetic Linkage | 1 | 2006 | 90 | 0.270 |
Why?
|
| Female | 19 | 2023 | 38021 | 0.270 |
Why?
|
| Haplotypes | 5 | 2013 | 174 | 0.260 |
Why?
|
| Apoptosis | 1 | 2012 | 1641 | 0.260 |
Why?
|
| Epigenomics | 2 | 2022 | 29 | 0.260 |
Why?
|
| Genetic Pleiotropy | 2 | 2018 | 10 | 0.260 |
Why?
|
| Transcriptome | 2 | 2023 | 164 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2012 | 20 | 0.220 |
Why?
|
| Computational Biology | 2 | 2021 | 190 | 0.210 |
Why?
|
| Causality | 1 | 2022 | 81 | 0.210 |
Why?
|
| Monocytes | 1 | 2023 | 210 | 0.200 |
Why?
|
| Male | 15 | 2021 | 37283 | 0.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1999 | 144 | 0.200 |
Why?
|
| Nucleic Acids | 1 | 2021 | 16 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 124 | 0.200 |
Why?
|
| Arthritis, Juvenile | 2 | 2012 | 70 | 0.200 |
Why?
|
| Africa | 1 | 2021 | 41 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2012 | 56 | 0.190 |
Why?
|
| Europe | 1 | 2021 | 196 | 0.190 |
Why?
|
| Genetic Markers | 2 | 2019 | 144 | 0.180 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 13 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2021 | 215 | 0.170 |
Why?
|
| Mucositis | 1 | 2019 | 9 | 0.170 |
Why?
|
| Autoantigens | 1 | 2019 | 91 | 0.170 |
Why?
|
| Systems Biology | 1 | 2019 | 25 | 0.170 |
Why?
|
| Chromosome Inversion | 1 | 1999 | 5 | 0.170 |
Why?
|
| Sequence Homology | 1 | 1999 | 11 | 0.170 |
Why?
|
| Birds | 1 | 1999 | 17 | 0.170 |
Why?
|
| Data Mining | 1 | 2019 | 45 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 299 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 118 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 74 | 0.160 |
Why?
|
| Skin | 1 | 2021 | 451 | 0.160 |
Why?
|
| Radiation Injuries | 1 | 2019 | 97 | 0.160 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2265 | 0.160 |
Why?
|
| Databases, Genetic | 1 | 2018 | 52 | 0.150 |
Why?
|
| Genetic Load | 1 | 2017 | 4 | 0.150 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 14 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2019 | 206 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 2 | 2012 | 24 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2017 | 2356 | 0.120 |
Why?
|
| Gene Frequency | 3 | 2010 | 207 | 0.120 |
Why?
|
| NADH Dehydrogenase | 1 | 2013 | 13 | 0.110 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 17 | 0.110 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 20 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 35 | 0.110 |
Why?
|
| Logistic Models | 3 | 2017 | 1419 | 0.110 |
Why?
|
| Drugs, Generic | 1 | 2012 | 17 | 0.110 |
Why?
|
| Albuterol | 1 | 2012 | 26 | 0.110 |
Why?
|
| Egg Proteins | 1 | 2012 | 15 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2021 | 2689 | 0.100 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 26 | 0.100 |
Why?
|
| Asymptomatic Diseases | 1 | 2012 | 43 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2012 | 43 | 0.100 |
Why?
|
| OX40 Ligand | 1 | 2011 | 7 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2012 | 2455 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 32 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2011 | 38 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 53 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2010 | 1 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Angiopoietin-1 | 1 | 2010 | 12 | 0.090 |
Why?
|
| Fibrosis | 1 | 2012 | 371 | 0.090 |
Why?
|
| Adult | 6 | 2018 | 21379 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 155 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 62 | 0.090 |
Why?
|
| HLA-DRB1 Chains | 1 | 2009 | 21 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 2 | 2017 | 24 | 0.080 |
Why?
|
| Asthma | 1 | 2012 | 345 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2022 | 706 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1085 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2005 | 301 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2010 | 276 | 0.080 |
Why?
|
| CD11b Antigen | 1 | 2008 | 47 | 0.080 |
Why?
|
| Genome, Human | 1 | 2008 | 62 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2005 | 56 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2012 | 617 | 0.080 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2019 | 230 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 216 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2006 | 15 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2006 | 18 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2010 | 880 | 0.070 |
Why?
|
| Food Technology | 1 | 2006 | 3 | 0.070 |
Why?
|
| Oocysts | 1 | 2006 | 2 | 0.070 |
Why?
|
| Cryptosporidium parvum | 1 | 2006 | 5 | 0.070 |
Why?
|
| Shellfish | 1 | 2006 | 8 | 0.070 |
Why?
|
| Bivalvia | 1 | 2006 | 10 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 290 | 0.070 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 171 | 0.070 |
Why?
|
| Animals | 6 | 2021 | 20880 | 0.060 |
Why?
|
| Algorithms | 2 | 2022 | 1195 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.050 |
Why?
|
| Phenotype | 2 | 2017 | 946 | 0.050 |
Why?
|
| Transcription Factor AP-2 | 1 | 2021 | 9 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 29 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2021 | 32 | 0.050 |
Why?
|
| Child | 4 | 2014 | 6401 | 0.050 |
Why?
|
| Phycodnaviridae | 1 | 2019 | 2 | 0.040 |
Why?
|
| Mimiviridae | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2019 | 35 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 52 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 236 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 136 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 14 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 230 | 0.040 |
Why?
|
| Publications | 1 | 2019 | 17 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2019 | 84 | 0.040 |
Why?
|
| Carcinogens | 1 | 2019 | 86 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 125 | 0.040 |
Why?
|
| Cricetinae | 1 | 2019 | 262 | 0.040 |
Why?
|
| Karyotyping | 1 | 1999 | 74 | 0.040 |
Why?
|
| DNA | 1 | 2021 | 597 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 951 | 0.040 |
Why?
|
| Fertility | 1 | 1999 | 60 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 1999 | 64 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 55 | 0.040 |
Why?
|
| Avian Leukosis Virus | 1 | 1998 | 7 | 0.040 |
Why?
|
| Proviruses | 1 | 1998 | 8 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 83 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1082 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 10 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 3703 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 144 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 89 | 0.040 |
Why?
|
| Age of Onset | 1 | 2017 | 188 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2021 | 447 | 0.040 |
Why?
|
| Internet | 1 | 2019 | 390 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2673 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 563 | 0.030 |
Why?
|
| Disease Progression | 2 | 2012 | 1037 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 621 | 0.030 |
Why?
|
| HLA-DR2 Antigen | 1 | 2014 | 4 | 0.030 |
Why?
|
| HLA-DR3 Antigen | 1 | 2014 | 7 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 955 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2012 | 3187 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 189 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2550 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2004 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 5300 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 21119 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 24 | 0.030 |
Why?
|
| Indians, North American | 1 | 2012 | 64 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2012 | 44 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 208 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 8904 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1663 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 5720 | 0.020 |
Why?
|
| Family | 1 | 2012 | 293 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 7028 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1738 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 7 | 0.020 |
Why?
|
| STAT4 Transcription Factor | 1 | 2008 | 12 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2008 | 32 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 242 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 238 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 14842 | 0.020 |
Why?
|
| Registries | 1 | 2010 | 730 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 392 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2006 | 5 | 0.020 |
Why?
|
| Portugal | 1 | 2006 | 7 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7338 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 7268 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2004 | 18 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 13 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2004 | 51 | 0.020 |
Why?
|
| North America | 1 | 2004 | 111 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2005 | 112 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5710 | 0.010 |
Why?
|
| Avian Leukosis | 1 | 1998 | 2 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1998 | 379 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 492 | 0.010 |
Why?
|